1. Home >
  2. Companies >
  3. Acquired >
  4. Distribution >
  5. United States >
  6. Michigan >
  7. The Harvard Drug Group >
  8. M&A

The Harvard Drug Group Mergers & Acquisitions

The Harvard Drug Group M&A Summary

The Harvard Drug Group has acquired 2 companies of its own. It has also divested 1 asset.

The Harvard Drug Group’s largest acquisition to date was in 2012, when it acquired The Rugby Group for $117M. It’s largest disclosed sale occurred in 2022, when it sold Letco Medical to Fagron NV for $34M. The Harvard Drug Group has acquired in 2 different US states. The Company’s most targeted sectors include distribution (50%) and medical products (50%).

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity2
    • M&A Sell Activity1
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2

The Harvard Drug Group LLC

31778 Enterprise Drive,
Livonia, Michigan 48150
United States,
(800) 875-0123
www.theharvarddruggroup.com

All (3) Buy (2) Sell (1)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2022-02-02 Letco Med · Medical Products
Wayne, Pennsylvania · www.letcomedical.com

Letco Med provides turnkey solutions for pharmacies worldwide, specializing in respiratory and compounded, customized medications, as well as technology-driven diagnostics. Letco Med offers a suite of pharmacy operations consulting, compounding chemicals, equipment and supplies, pre-mix medications, and industrial facilities equipment. Letco Med is based in Wayne, Pennsylvania.

34 Divestiture

Fagron

The Harvard Drug Group LLC


Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal